TumorSight Dose

About SimBioSys

SimBioSys is a private, clinical-stage company leveraging artificial intelligence, spatial biophysics, and data science to create comprehensive 3D models of solid tumors. Its core platform, PhenoScope, generates 'digital twins' to simulate drug distribution and tumor response, aiming to answer critical clinical questions across surgery, therapy selection, and dosing. While its first commercial product is an FDA-cleared surgical visualization tool for breast cancer, the company has a broader pipeline of in-development diagnostic and predictive software tools for various solid tumors.

Therapeutic Areas